# A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor

> **NCT00941902** · — · COMPLETED · sponsor: **Ziv Hospital** · enrollment: 148 (actual)

## Conditions studied

- Liver Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00941902
- **Lead sponsor:** Ziv Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-09
- **Final completion:** 2011-02
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941902, "A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00941902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*